GlassScriptPhysician profile
Jennifer Cribb
NPI 1093047086
$6,601.64
in general payments reported to CMS, 2019-2025
47 companies · $1,336 in 2025
The $1,336 reported for 2025 was more than what 91% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $939 · 2022: $1,438 · 2023: $1,258 · 2024: $1,631 · 2025: $1,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,064 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,063.71 |
| Education | $160.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $833.79 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $743.22 | 2021-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $669.73 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $600.98 | 2022-2025 | |
| Amgen INC. | $487.54 | 2021-2025 | Otezla, Repatha, Repatha |
| Abbvie INC. | $417.09 | 2021-2025 | |
| Lilly USA, LLC | $400.50 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $296.77 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Otsuka America Pharmaceutical, INC. | $216.36 | 2021-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.93 | 2021-2025 | Jardiance |
| Abbott Laboratories | $198.65 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $152.37 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $116.59 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $115.88 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $107.25 | 2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Cribb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.